FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, and more specifically to an antidiabetic composition. What is offered is a pharmaceutical composition containing Glimepiride, poloxamer, sodium croscarmellose and other excipients - povidone, lactose monohydrate, microcrystalline cellulose, stearic acid salt and a colourant.
EFFECT: pharmaceutical composition is characterised by high therapeutic activity, satisfactory technical characteristics and shelf life of more than 2 years.
11 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL ANTIDIABETIC COMPOSITION AND METHOD OF OBTAINING ANTIDIABETIC COMPOSITION | 2011 |
|
RU2482846C2 |
| PELLETISED DRUG SHOWING ANTIVIRAL AND INTERFERONOGENIC ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2449792C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CONGESTIVE CARDIAC FAILURE AND METHOD FOR PREPARING IT | 2011 |
|
RU2479310C2 |
| PHARMACEUTICAL COMPOSITION FOR ALLERGIC DISEASES | 2010 |
|
RU2453315C2 |
| SOLID DRUG FORM OF IMIPRAMINE WITH IMMEDIATE RELEASE AND METHOD OF OBTAINING THEREOF | 2016 |
|
RU2609198C1 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED FORMULATION CONTAINING A GLUCOKINASE ACTIVATOR AND A KATP CHANNEL BLOCKER, METHOD FOR PRODUCTION AND APPLICATION THEREOF | 2019 |
|
RU2772875C1 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
| HYPOLIPIDEMIC DOSAGE FORM AND METHOD FOR PREPARING IT | 2013 |
|
RU2547574C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING AND USING DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION CONTAINING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2818092C1 |
